Zimbabwe has withdrawn from negotiations on a US$350 million health agreement, citing sovereignty concerns, while the US ...
Zimbabwe explains why President Mnangagwa rejected US$367 million US health funding for HIV, TB, and malaria treatment. Government spokesman Nick Mangwana cites sovereignty concerns over demands for ...
The US launches long-acting HIV prevention drug lenacapavir in Zimbabwe, aiming to support thousands of people.
The United States Government announced US$45 million in funding to respond to the critical food security situation in the upcoming lean season between October 2019 and March 2020 in Zimbabwe.
The United States is winding down a major health aid program to Zimbabwe following failed negotiations over data sharing and sovereignty concerns. The proposed USD 367 million deal aimed to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results